Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
7.10
-0.04 (-0.56%)
At close: Sep 4, 2026, 4:00 PM EDT
7.07
-0.03 (-0.42%)
After-hours: Sep 4, 2026, 7:58 PM EDT
Precigen Employees
Precigen had 160 employees as of December 31, 2025. The number of employees increased by 17 or 11.89% compared to the previous year.
Employees
160
Change (1Y)
17
Growth (1Y)
11.89%
Revenue / Employee
$535,731
Profits / Employee
-$2,104,406
Market Cap
2.54B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 160 | 17 | 11.89% | 160 | 0 |
| Dec 31, 2024 | 143 | -59 | -29.21% | 143 | 0 |
| Dec 31, 2023 | 202 | -7 | -3.35% | 202 | 0 |
| Dec 31, 2022 | 209 | -302 | -59.10% | 209 | 0 |
| Dec 31, 2021 | 511 | 34 | 7.13% | 456 | 55 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Vera Therapeutics | 361 |
| Nurix Therapeutics | 317 |
| Nuvation Bio | 305 |
| Harmony Biosciences Holdings | 293 |
| Biohaven | 274 |
| Viridian Therapeutics | 252 |
| Pharvaris | 148 |
PGEN News
- 13 days ago - Precigen Q2 marked commercial inflection - TheFly
- 13 days ago - Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers - Accesswire
- 4 weeks ago - Precigen price target raised to $18 from $14 at H.C. Wainwright - TheFly
- 4 weeks ago - Precigen Earnings Call Transcript: Q2 2026 - Transcripts
- 4 weeks ago - Precigen Earnings release: Q2 2026 - Filings
- 4 weeks ago - Precigen Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Precigen reports Q2 EPS 5c vs., (9c) last year - TheFly
- 4 weeks ago - Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth - PRNewsWire